INTRODUCTION
Long QT syndrome (LQTS) is a disorder of ventricular repolarization that predisposes affected individuals to cardiac arrhythmia and sudden death. Inherited LQTS is caused by mutations in K + or Na + ion channel genes or ankyrin-B (1,2). Acquired LQTS is more common and can be induced as an unintended and rare side effect of treatment with many structurally diverse medications. In the past few years, several commonly used drugs (e.g., terfenadine, cisapride, sertindole, thioridazine, grepafloxacin) were withdrawn from the market, or their approved use severely restricted when it was discovered, albeit very infrequently, they caused arrhythmia or were associated with unexplained sudden death (3) . The molecular basis of druginduced LQTS is block of human ether-a-go-go related gene (hERG) channels that conduct I Kr , the rapid delayed rectifier K + current important for repolarization of cardiac action potentials (4, 5) . A reduction in I Kr prolongs action potential duration of ventricular myocytes, lengthens the QT interval and increases dispersion as measured by ECG recordings and increases the risk of torsades de pointes, a ventricular tachyarrhythmia that can degenerate into fibrillation and cause sudden death. In a laboratory setting, it is possible to induce arrhythmia in animals with drugs that block voltage-gated K + (Kv) channels other than hERG. However, in clinical practice, druginduced LQTS is always attributable to direct or indirect (via interference with metabolism of a co-administered medication) block of hERG channels (6) . This understanding has prompted intense efforts to quantify hERG channel activity of new chemical entities during an early stage of the drug development process (6, 7) .
A better understanding of the molecular basis of hERG channel block could facilitate computer-assisted drug design and enable pre-synthetic, virtual screening of compounds for hERG activity. Moreover, a description of the physicochemical features of the drug binding site would complement pharmacophore models (8, 9) of drugs that block hERG channels and define the molecular basis for receptor fields predicted by these models. Towards this goal, we have used site-directed mutagenesis and voltage clamp analysis of mutant channels expressed in Xenopus oocytes to elucidate the molecular mechanisms of hERG channel block by structurally diverse drugs, including MK-499, cisapride, terfenadine, vesnarinone, chloroquine and quinidine (10) (11) (12) (13) . These studies identified two aromatic residues, Tyr-652 and Phe-656, located in the S6 domain and predicted to face the central cavity of the channel (Fig. 1a ) that are critical for high affinity binding of these drugs. Kv channels of the Kv1-4 families have an Ile or Val residue in the positions equivalent to Tyr-652 or Phe-656 of hERG (Fig. 1b) . This suggests a plausible explanation for why hERG and not Kv1-4 channels are readily blocked by structurally diverse drugs: aromatic residues in S6 are required for high affinity binding. In addition, Kv1-4 channel α-subunits have a Pro-Val(Ile)-Pro motif in the S6 domain that was suggested to cause a bend in the α-helix and alter the shape of the central cavity compared to that predicted for KcsA, a K + channel that lacks these Pro residues. The S6 domain of hERG also lacks the Pro-Val-Pro motif and instead has the residues Ile-Phe-Gly in the equivalent positions. Thus, we previously proposed that aromatic residues (two on each subunit, eight per channel) that face the inner cavity, and the lack of the Pro-Val-Pro motif, were important determinants of the high affinity hERG channel binding site (10) . EAG channels also lack a Pro-Val-Pro motif and have a Tyr and Phe in the S6 domain, but are relatively insensitive to drugs that block hERG. However, EAG channels were made sensitive to block by cisapride by moving the Tyr residue by one position in the S6 domain (14) .
Pharmacophore models predict that important features of potent hERG channel blockers are 1) a basic nitrogen that is usually protonated at physiological pH, and 2) three hydrophobic centers of mass (centroids) arranged in a specific spatial pattern around the centrally located nitrogen (8, 9) . For many potent hERG blockers, these centroids are aromatic groups. We and others have postulated that π-stacking between aromatic groups of the drug and Phe-656 and Tyr-652 of hERG are required for high affinity binding and channel block (10, 15) . In addition, because most hERG blockers contain a basic nitrogen, it has been suggested that cation-π interactions with Tyr-652 or Phe-656 might also be required for high affinity binding to the channel. In this study we systematically investigated these hypotheses by mutating Tyr-652 and
Phe-656 to several other amino acids and determined the sensitivity of the resulting mutant channels to block by cisapride, MK-499 and terfenadine. A quantitative comparison between the IC 50 values for the mutant channels and the physicochemical properties of the side chain of the mutant residues was used to provide further insights into the molecular features of the hERG binding site.
EXPERIMENTAL PROCEDURES
Molecular biology − Point mutations of hERG subcloned into the pSP64 plasmid expression vector (Promega, Madison, WI) were made as described (10 The search for predictive subsets of descriptors was performed using a simulated annealing feature selection algorithm (18) included in the ADAPT software package (19, 20) . Simulated annealing is an optimization algorithm that has found widespread use in the area of variable selection in computational correlation studies. The algorithm attempts to identify subsets of descriptors that best correlate with the experimental endpoint of interest. In many cases, the direct relevance of descriptors selected to the property being studied is observed. The optimal descriptor subset, or model, is identified as that which minimizes the root-mean-square error (Table 1 ). An exception was the F656W mutation that shifted V 1/2 by -25 mV. Most of the mutations induced significant changes in the rate of deactivation, but K + selectivity was not altered based upon the lack of effects on reversal potential of the current (Table 1 ). There was no correlation between the kinetics of activation or deactivation and physicochemical parameters such as hydrophobicity, nonpolar surface area, or volume of the side group for the amino acid substituted for Phe (data not shown). Mutation of Phe-656 to Gly, Ser, Arg or Glu reduced functional expression and disrupted closure of channels ( Fig. 2c) and therefore, the voltage-dependence and kinetics of gating were not determined for these mutant channels.
Hydrophobicity of residue 656 determines potency of hERG channel blockers − The sensitivity of Phe-656 mutant channels to drugs was determined by measuring the decrease in current activated by 5-s pulses applied repetitively to 0 mV. Examples of steady-state block of WT and five mutant Phe-656 hERG channels achieved with 1 or 10 µM MK-499 are shown in Fig. 3a . Concentration-response relationships for MK-499 for these same channels are plotted in increased by a factor of 1.8 and 3.3, respectively). In contrast, the IC 50 was increased by over 3 orders of magnitude when Phe-656 was mutated to Gly, Glu or Arg, mutations that also severely disrupted channel gating (Fig. 2c) . Unexpectedly, the IC 50 for MK-499 was only moderately increased when Phe-656 was mutated to the nonaromatic residues Met, Leu or Ile. For these residues, the IC 50 was increased by a factor of 3.7, 7.8 and 11, respectively ( Table 2) . We also determined the sensitivity of all 12 mutant channels to block by cisapride ( Fig. 3c ) and terfenadine ( Fig. 3b ). Similar to MK-499, the IC 50 's for these drugs were only slightly changed when Phe656 was mutated to Tyr or Trp and increased the most by mutation to Gly or Arg (Table 2) . Again, mutation of Phe-656 to the hydrophobic residues Met, Leu, or Ile had little or no effect on channel sensitivity to block by cisapride and terfenadine.
Block of hERG by some drugs (e.g., quinidine and chloroquine) is voltage dependent (12, 13) and therefore the test potential chosen to determine IC 50 can be important. However, MK-499 (22) , and terfenadine (23) do not block hERG in a voltage dependent manner, and cisapride exhibits only modest voltage dependence (24) . The only Phe-656 mutation that significantly altered the voltage dependence of gating was F656W; however, the IC 50 values for this mutant channel were not significantly altered. We also tested for voltage dependence of block for F656T and F656M. Block was voltage independent for both mutant channels by all three drugs (n = 4-6 each drug, data not shown). Thus, it is appropriate to measure block of hERG by these drugs at 0 mV to determine IC 50 values.
The logarithmic value for the fold-change in IC 50 (relative to WT hERG) for each mutant channel was regressed as a function of a variety of physical and calculated properties of the amino acids substituted for Phe-656. The parameters chosen for regression analysis were three physical parameters; the side-chain surface area, free energies of transfer from octanol to neutral aqueous solution, and buried residue non-polar surface area, and the 115 calculated 2-D descriptors from MOE. For all parameters investigated, the correlation was highest for MK-499
and weakest for terfenadine. The calculated descriptor that was best correlated with logarithmic fold change in IC 50 , for all three compounds, was the 2-D van der Waals hydrophobic surface area (VHSA). VHSA is calculated by summing the approximate van der Waals surface areas of atoms deemed "hydrophobic" in character. VHSA accounts for the hydrophobicity of the sulfur atom of Met and was thus superior in predictive power to the non-polar surface area physical parameter, which does not take this into account. Table 3 summarizes the correlation coefficients (R 2 ) for the linear regression plots of physicochemical descriptors versus experimental log(fold-change in IC 50 ). Fig. 4 shows a plot of the predicted versus experimental log(fold-change in IC 50 ) for the three drugs based on the VHSA values using ADAPT as described in Methods. Predicted values for additional residues can be determined by inserting the VHSA value for the residue into each of the three equations presented in the legend of Fig. 4 .
The correlation between VHSA and experimental values were further improved if the data points for residues that significantly altered the channel gating were removed from the analysis.
The correlation coefficients for analyses without Arg, and without Arg, Glu, Gly, and Ser are included in Table 3 . Other calculated descriptors related to hydrophobicity demonstrated high correlations as well, including the Crippen fragment-derived logP estimator (SlogP) (25) , a linear logP model estimator (logP (octanol/water); from P. Labute in MOE), and a simple count of the number of "hydrophobic" atoms. SlogP and logP (octanol/water) differ from VHSA in that they account for all atoms in each residue, rather than just the hydrophobic atoms. In addition to hydrophobicity measures, descriptors encoding the sums of 2-D van der Waals surface areas of partially positive atoms and partially negative atoms, separately, were among the more highly correlated metrics, but not as highly correlated as the hydrophobicity measures. When considering the full dataset (i.e., all three compounds and all 13 amino acids), VHSA was the most highly correlated descriptor and possessed the most statistical significance (F-test, t-test, Pvalue). SlogP and logP (octanol/water) were always the second and third most highly correlated descriptors, respectively, indicating a clear consensus that hydrophobicity is a driving force behind the observed data.
The simulated annealing algorithm was used to search for optimal two-descriptor models, and identified the combination of VHSA and nN, the number of nitrogen atoms, as a superior predictor of log(fold-change in IC 50 ) for all three compounds. In this context, nN is merely a correction factor for residues that contain more than one nitrogen atom (i.e., Trp and Arg). The R 2 values obtained from these regression analyses are listed in Table 3 . A better fit could also be obtained by omitting Arg from the analysis ("No Arg", (Fig. 1b) . Tyr-652 was mutated to eight other residues (Phe, Trp, Ala, Val, Glu, Gln, Ile, Thr) to determine the effect of changing the volume, size, polarity and hydrophobicity of the side group on drug sensitivity. Mutations of Tyr-652 were well tolerated and the mutant channels retained K + selectivity and relatively normal biophysical properties (Fig. 5 , Table 1 ).
Drugs might interact by H-bonding to the hydroxyl group or via cation-π or π-stacking with the phenol of Tyr-652. Mutation of Tyr-652 to Phe or Trp reduced or did not significantly change the sensitivity to MK-499 ( Fig. 6a and b) , and like WT hERG, block of current was voltage-independent (data not shown). Similar results were obtained for cisapride (Fig. 6c) and terfenadine ( Fig. 6d) , indicating that although an aromatic group may be favored, a phenol sidechain is not an essential feature of this residue for drug sensitivity. Y652T hERG was insensitive to 30 µM MK-499 (Fig. 6a ) and greatly reduced sensitivity to cisapride and terfenadine ( Fig. 6c and d), providing additional evidence for the lack of importance of the hydroxyl group of Tyr-652. Mutation of Tyr-652 to other polar (Glu, Gln) or hydrophobic (Ala, Val, Ile) residues also greatly reduced drug block ( Fig. 6b-d) . For example, the IC 50 for MK-499 was 29 µM for Y652V and >30 µM for Y652Q. The effect of Tyr-652 mutations on IC 50 values for all three drugs are summarized in Table 2 . The mutation Y652Q shifted the voltage dependence of activation by +14 mV (Table 1) , but block by 30 µM cisapride was voltage-independent. For example, the reduction of outward current varied between 12 and 17 % at test potentials ranging from -50 mV to +50 mV (n = 3). Block of Y652F (n = 4) and Y652W (n = 3) hERG channels by all three drugs were also independent of voltage over this range of potentials (data not shown).
There was only a poor correlation between hydrophobic volume of residue 652 and sensitivity to drugs. For example, the R 2 value for the plot of VHSA and log(fold-change in IC 50 )
for MK-499 was 0.52 (P = 0.07). The correlation coefficient for this relationship was improved for cisapride (R 2 = 0.63; P = 0.02) and terfenadine (R 2 = 0.69; P = 0.01). However, the distribution of concentration-response relationships was bimodal and there was no correlation between log(fold-change in IC 50 ) vs drug concentration (R 2 < 0.06; P > 0.65) when the aromatic residues were removed from the analysis. By comparison, the relationship between VHSA and log(fold-change in IC 50 ) for the non-aromatic Phe-656 mutant channels remained statistically significant (R 2 = 0.97, 0.90 and 0.95 for MK-499, cisapride and terfenadine, respectively; P < 0.0001). We conclude that an aromatic side group for residue 652 is required to retain high potency block by these three drugs.
Introduction of Pro-Val-Pro Motif into S6 Domain of hERG Alters Channel Gating and
Reduces Drug Sensitivity − Most Kv channels have a Pro-Val-Pro motif in the S6 domain ( 
DISCUSSION
We previously reported that the most important determinants of the drug binding site of hERG were two aromatic residues located in the S6 domain (10) . Here we extend these findings to show that hydrophobic volume of Phe-656 and aromaticity of Tyr-652 determine the sensitivity of hERG to block by structurally diverse drugs known to cause acquired LQTS.
Mutation of Phe-656 to Ile, Leu, Met, Trp or Tyr caused modest changes in biophysical properties of the channel and IC 50 for block by MK-499, cisapride or terfenadine. In contrast, mutation of Phe-656 to Gly, Ser, Arg or Glu disrupted channel closure and markedly decreased drug sensitivity. However, change in drug sensitivity was not clearly related to disrupted gating.
For example, although the kinetics and voltage dependence of gating for F656M and F656T were similar (and like WT hERG), F656M retained normal drug sensitivity whereas F656T was relatively insensitive ( Table 2) . VHSA of the amino acid side group was the best predictor of altered potency of drug block induced by mutation of Phe-656.
The unique position of Phe-656 in the S6 domain of hERG may explain why the gating of F656G(S/A/R/E) mutant channels was disrupted. Homology models of the hERG channel pore based on the x-ray coordinates of KcsA (27) or MthK (28) channels suggest that Phe-656 residues from all four subunits face towards the inner cavity and towards one another in the putative closed and open state conformations of the channel. In the closed state, the Phe-656 residues form the walls of a narrow constriction. Mutation of Phe-656 to residues with small side chains (Gly, Ala, Ser) might increase the diameter of the constriction so when the channel is in the "closed" state, it is still capable of conducting K + ions. An increase in the volume of the side chain by a single methyl group (from Ala to Val, or Ser to Thr) is sufficient to permit normal channel closure. Electrostatic repulsion might explain why channels with Phe-656 mutated to the charged residues Glu and Arg did not close at negative transmembrane potentials. Introduction of a Pro-Val-Pro motif into the S6 domain of hERG also greatly reduced drug sensitivity.
However, the significance of this finding is questionable because the Pro-Val-Pro also dramatically altered gating properties of the channel.
An aromatic side group for residue 652 was required to maintain drug sensitivity. We (13) and others (8, 29) previously suggested that the basic nitrogen of hERG channel blockers could form a cation-π interaction with Tyr-652. Cavalli et al (8) It is important to note that not all hERG channel blockers bind to the exact same receptor site. For example, we previously noted (10) that block of hERG by MK-499 was affected greatly, but hardly at all by cisapride or terfenadine with mutations of Val-625, located at the base of the pore helix or Gly-648, the residue proposed to be the hinge point for flexure of the S6 domain during channel opening (28) . Thus, although all three drugs interact with Tyr-652 and Phe-656, they differ with respect to interaction with residues located closer to the selectivity filter. In addition, some low potency blockers of hERG do not appear to interact as strongly with the S6 aromatic residues. For example, block of hERG by fluvoxamine is only slightly affected by F656A or Y652A mutations (30) , suggesting that other residues are more critical components of the binding site for this drug (31) .
In summary, the potency for block of hERG channels by three structurally diverse drugs (MK-499, cisapride, terfenadine) was well correlated with the 2-D approximation of the van der Waals hydrophobic surface area for the side chain of residue 656, and was not related to aromaticity per se. In contrast, an aromatic side group at residue 652 was essential for high affinity block, suggesting the importance of a cation-π interaction between Tyr-652 and the basic nitrogen of the drugs. Together, these findings provide a refined molecular understanding of the hERG binding site and assigns specific residues to the receptor steric fields previously predicted Table 2 . , WT; , F656W; , F656V; , F656T; , F656M; ▲, F656Y; ►, F656L; ◄, Table 3 . Table 1 ).
Currents were normalized to peak values. , WT; , Y652W; , Y652T; ▲, Y652F; ○, Y652V; ∆, Y652Q; ◄, Y652I; , Y652E. Table 2 . , WT; , Y652W; , Y652T; ▲, Y652F; ○, Y652V; ∆, Y652Q; ◄, Y652I; , Y652E. *P < 0.05, **P < 0.01. Glu 0% @ 30µM ->700 0% @ 30µM ->250 36% @ 30µM ->200 Charge a h = Hill coefficient * P < 0.05, ** P < 0.01. (n = 4 -8). Side chain area = total surface area (Å 2 ) of the amino acid side chain (32); Non-polar surface area (33); Octanol-water = free energies of transfer (kcal/mol) from octanol to dilute aqueous solution at pH 7 (34) . VHSA = van der Waals hydrophobic surface area (Å 2 ) calculated using the MOE software package. VHSA + nN = weighted descriptors (nN = # of nitrogens in amino acid). 
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